Catalyst Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Sell
19,150
-475
-2% -$98.7K 0.08% 71
2026
Q1
$4.15M Sell
19,625
-800
-4% -$172K 0.08% 70
2025
Q4
$4.2M Sell
20,425
-250
-1% -$47K 0.09% 79
2025
Q3
$3.25M Sell
20,675
-1,403
-6% -$217K 0.07% 91
2025
Q2
$3.71M Sell
22,078
-949
-4% -$141K 0.07% 83
2025
Q1
$3.17M Buy
23,027
+22,301
+3,072% +$2.84M 0.06% 87
2024
Q4
$85.9K Buy
726
+588
+426% +$68.6K ﹤0.01% 324
2024
Q3
$15.3K Buy
+138
New +$14.4K ﹤0.01% 496
2016
Q4
Sell
-745
Closed -$58K 418
2016
Q3
$58K Sell
745
-95,255
-99% -$7.7M 0.01% 312
2016
Q2
$7.49M Sell
96,000
-17,980
-16% -$1.43M 1.38% 6
2016
Q1
$9.34M Sell
113,980
-14,403
-11% -$1.17M 1.57% 7
2015
Q4
$11.5M Buy
128,383
+115,883
+927% +$9.84M 1.66% 7
2015
Q3
$960K Buy
+12,500
New +$1.04M 0.13% 146
2013
Q3
Sell
-14,787
Closed -$698K 287
2013
Q2
$698K Buy
+14,787
New +$675K 0.54% 58

Other funds holding CAH

Catalyst Capital Advisors's CAH Position: Q2 2026 in Review

Catalyst Capital Advisors reduced its Cardinal Health (CAH) stake by 2.4% in Q2 2026, selling an estimated $98.7K and leaving 19,150 shares worth $4.55M. The position accounts for 0.08% of the portfolio, ranked #71.

Catalyst Capital Advisors first reported a position in CAH in Q2 2013 and has held it in 14 quarters since. The position peaked at $11.5M in Q4 2015. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Catalyst Capital Advisors held 19,150 shares of Cardinal Health worth $4.55M as of Q2 2026.
  • Catalyst Capital Advisors sold 475 Cardinal Health shares in Q2 2026, an estimated $98.7K.
  • Cardinal Health made up 0.08% of Catalyst Capital Advisors's portfolio in Q2 2026, its #71 holding.
  • Catalyst Capital Advisors first reported a position in Cardinal Health in Q2 2013 and has held it in 14 quarters since.
  • Catalyst Capital Advisors's Cardinal Health position peaked at $11.5M in Q4 2015.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.